Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment
Phase 2
- Conditions
- Alveolitis Extrinsic AllergicPulmonary Fibrosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2015-07-14
- Lead Sponsor
- Grupo Medifarma, S. A. de C. V.
- Target Recruit Count
- 60
- Registration Number
- NCT02496182
- Locations
- 🇲🇽
Instituto Nacional de Enfermedades Respiratorias, Mexico city, Distrito Federal, Mexico
News
No news found